Corrigendum: Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy

Hum Mol Genet. 2019 May 15;28(10):1752. doi: 10.1093/hmg/ddz021.

Sophie Belin^{1

2

3}, Francesca Ornaghi^{1

2

4

5}, Ghjuvan'Ghjacumu Shackleford^{1

6}, Jie Wang², Cristina Scapin⁴, Camila Lopez-Anido⁷, Nicholas Silvestri⁶, Neil Robertson², Courtney Williamson¹, Akihiro Ishii⁸, Carla Taveggia⁹, John Svaren⁷, Rashmi Bansal⁸, Markus H Schwab^{10

11}, Klaus Nave¹⁰, Pietro Fratta¹², Maurizio D'Antonio⁴, Yannick Poitelon³, M Laura Feltri^{1

2

6

4}, Lawrence Wrabetz^{1

2

6

4}

¹ Hunter James Kelly Research Institute, University at Buffalo, Buffalo, NY, USA.
² Department of Biochemistry, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.
³ Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, New York, USA.
⁴ Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy.
⁵ SR-TIGET, IRCCS, San Raffaele Scientific Institute, Milan, Italy.
⁶ Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.
⁷ Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.
⁸ Department of Neuroscience, University of Connecticut Medical School, Farmington, CT, USA.
⁹ Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
¹⁰ Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
¹¹ Department of Cellular Neurophysiology, Hannover Medical School, Hannover, Germany.
¹² Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.

No abstract available

Publication types